Modified dipeptide-based nanoparticles: vehicles for targeted tumor drug delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery

Background:

• Conventional nanoparticles for chemotherapy face challenges in synthesis and biocompatibility.
• There is a need for safe and effective nanocarriers for targeted cancer therapy.

Purpose of the Study:

• To develop self-assembled, amphipathic dipeptide nanoparticles using α,β-dehydrophenylalanine.
• To evaluate these nanoparticles for tumor-targeted drug delivery and therapy.

Main Methods:

• Dipeptides were synthesized using solution-phase peptide synthesis.
• Nanoparticles were formed via molecular self-assembly.
• Tumor targeting and regression were assessed using radiolabeling and in vivo studies in mice.

Main Results:

• Arginine-α,β-dehydrophenylalanine formed self-assembling nanoparticles.
• Folic acid conjugation enhanced cellular uptake and tumor regression when loaded with doxorubicin.
• The doxorubicin-loaded nanoparticles demonstrated efficacy without adverse side effects.

Conclusions:

• Dipeptide-based nanoparticles offer a promising platform for targeted cancer drug delivery.
• Folic acid derivatization enhances nanoparticle targeting and therapeutic efficacy.
• These nanoparticles represent a safe and effective alternative for chemotherapy.